The widely used glycated haemoglobin (HbA1c) test, considered the gold standard for diagnosing and monitoring Type-2 Diabetes (T2D), may produce misleading results in South Asian populations—particularly in India—due to the high prevalence of certain blood disorders, according to an article published in The Lancet Regional Health: Southeast Asia. Researchers have flagged concerns that conditions such as anaemia, haemoglobinopathies (including sickle cell disease and thalassaemia), and glucose-6-phosphate dehydrogenase (G6PD) deficiency can Read More …
